Takeda surpasses analyst forecasts in Q1
Bloomberg reports that Takeda Pharmaceuticals surpassed analyst predictions in the first quarter of the year.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Takeda Pharmaceuticals, whose partner is Danish Lundbeck, surpassed analyst predictions in the first quarter, according to Bloomberg News.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck to trial migraine drug in young people
For subscribers
